期刊文献+

胆管癌患者血清IL-6和粘附分子的检测及其临床意义 被引量:1

Determination of sera IL-6 and soluble adhesion molecules and their clinical significance
暂未订购
导出
摘要 目的:检测胆管癌患者血清IL-6和粘附分子P-选择素(P-sel)、细胞间粘附分子-1(1CAM-1)的水平,并探讨其临床意义。方法:采用ELISA法检测39例胆管癌患者、33例良性胆管疾病患者和30例正常人血清IL-6、P-sel和ICAM-1水平。结果:胆管癌患者血清IL-6、P-sel和ICAM-1水平均显著高于良性胆管疾病患者和正常入,且IL-6的水平与P-selI、CAM-1呈正相关,但高分化胆管腺癌与中分化胆管腺癌患者比较三项指标均无显著性差异;良性胆管疾病患者血清IL-6、P-sel和ICAM-1水平有所升高,与正常人比较差异有显著性。结论:胆管癌患者血清IL-6、P-sel和ICAM-1水平显著升高,提示粘附分子在胆管癌发病中可能起一定作用,检测P-sel和ICAM-1对胆管癌的辅助诊断具有重要意义。 Objective: To detect IL-6, P-selectin (P-sel) ahd intercellular adhesion molecule-1 in sera of the patients with cholangiocarcinoma, and to study their clinical significance. Methods : The concentration of IL-6, P-sel and ICAM-1 in sera of 39 patients with cholangiocarcinoma, 33 patients with benign lesion in biliary ducts and 30 normal volunteer were detected by ELISA. Results: The concentration of IL-6, P-sel and ICAM-1 in sera of the patientes with cholangiocarcinoma were obviously higher than that in the patientes with benign lesion inbiliary ducts and in normal volunteer, meanwhile the level of IL-6 was correlated to P-sel and ICAM-1 positively, but there were no difference of the concentration of 1L-6, P-sel and ICAM-1 between the patientes with well-differentiated bile duct adenocarcinoma and moderately differentiated bile duct adenocarcinoma. The concentration of IL-6, P-sel and ICAM-1 in sera of the pa tientes with benign lesion in biliary ducts were higher than that in normal volunteer. Conclusion : The concentration of IL-6, P-sel and ICAM-1 in sera of the patientes with cholangiocarcinoma were elevated, which indicated that P-sel and ICAM-1 play a role in cholangiocarcinoma and the detection of P-sel and ICAM-1 might be a useful tool in auxiliary diagnosis of cholangiocarcinoma.
出处 《河南医学研究》 CAS 2006年第3期247-249,共3页 Henan Medical Research
基金 湛江市科技攻关项目(编号:200521)
关键词 胆管癌 IL-6 P-选择素 ICAM-1 cholangiocarcinoma IL-6 P-selectin intercellular adhesion molecule-1
  • 相关文献

参考文献14

二级参考文献15

  • 1NakeebA, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors[J]. Ann Surg ,1996,224:463
  • 2lillemoe KD. Surgery for hilar cholangiocarcinoma[J]. J Heptobiliary Pancreat Surg, 2000, 7(2): 115-121
  • 3Patel AH, Harnosis DM, Klee G, et al.The utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis[J]. Am J Gastroenterol, 2000, 95(1):204-207
  • 4Dubaniewicz A. Cholangiocarcinoma-bile ducts cancer [J]. Wild Lek, 2003; 56 (1-2) : 57-60
  • 5Patel AH, The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis [J]. AM J Gastroenterol, 2000,95 (1): 204-207
  • 6Mann DV, Edwards R, Ho S. Elevated tumour marker CA19-9:clinical interpretation and influence of obstructive jaundice[J].Eur J Surg Oncol,2000 Aug;26(5):474-9.
  • 7Watanabe M, Chigusa M, Takahashi H, High level of CA19-9,CA50, and CEA-producible human cholangiocarcinoma cellline changes in the secretion ratios in vitro or in vivo[J]. In Vitro Cell Dev Biol Anim ,2000;36(2): 104-9
  • 8Carpelan-Holmstrom M, Louhimo J, Stenman UH,et al. CEA,CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers [J]. Anticancer Res, 2002; 22 (4): 2311-
  • 9Li J, Zhang Z, Rosenzweig J, Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer[J]. Clin Chem,2002;48(8) :1296-304.
  • 10Vlahou A, Schellhammer PF, Mendrinos S, Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine[J]. Am J Pathol, 2001; 158(4):1491-502.

共引文献22

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部